JTL
NAMS icon

Jupiter Topco LLC’s NewAmsterdam Pharma NAMS Stock Holding History

Jupiter Topco LLC’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$86M Buy
+2,535,682
New +$83.6M 0.04% 341

Other funds holding NAMS

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Jupiter Topco LLC's NAMS Position: Q2 2026 in Review

Jupiter Topco LLC opened a new position in NewAmsterdam Pharma (NAMS) in Q2 2026: 2,535,682 shares worth $86M. The stake represents 0.04% of the portfolio and ranks #341 among its holdings.

178 funds tracked by Wall St. Rank hold NAMS as of Q2 2026.

  • Jupiter Topco LLC held 2,535,682 shares of NewAmsterdam Pharma worth $86M as of Q2 2026.
  • NewAmsterdam Pharma was a new Jupiter Topco LLC position in Q2 2026.
  • NewAmsterdam Pharma made up 0.04% of Jupiter Topco LLC's portfolio in Q2 2026, its #341 holding.
  • 178 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q2 2026.

Based on Jupiter Topco LLC's 13F filing for Q2 2026, filed 14 Aug 2026.